Works matching IS 02724391 AND DT 2003 AND VI 59 AND IP 1
1
- Drug Development Research, 2003, v. 59, n. 1, p. 161, doi. 10.1002/ddr.10217
- Roberta Brambilla;
- Joseph T. Neary;
- Marta Fumagalli;
- Lorenzo Cottini
- Article
2
- Drug Development Research, 2003, v. 59, n. 1, p. 175
- Heike Franke;
- Ute Krügel;
- Jens Grosche;
- Peter Illes
- Article
3
- Drug Development Research, 2003, v. 59, n. 1, p. 118, doi. 10.1002/ddr.10209
- Irma Lemaire;
- Natacha Leduc
- Article
4
- Drug Development Research, 2003, v. 59, n. 1, p. 104, doi. 10.1002/ddr.10208
- Shinya Ueno;
- Tomoko Moriyama;
- Kenji Honda;
- Hiro-o Kamiya;
- Tsukasa Sakurada;
- Takeshi Katsuragi
- Article
5
- Drug Development Research, 2003, v. 59, n. 1, p. 95
- Ute Krügel;
- Bertholt Seidel;
- Oliver Spies;
- Holger Kittner;
- Peter Illes;
- Wieland Kiess
- Article
6
- Drug Development Research, 2003, v. 59, n. 1, p. 88, doi. 10.1002/ddr.10206
- Schuichi Koizumi;
- Kayoko Fujishita;
- Makoto Tsuda
- Article
7
- Drug Development Research, 2003, v. 59, n. 1, p. 36, doi. 10.1002/ddr.10200
- Eric A. Barnard;
- Joseph Simon;
- Karl W.K. Tsim;
- Alexander K. Filippov;
- David A. Brown
- Article
8
- Drug Development Research, 2003, v. 59, n. 1, p. 112, doi. 10.1002/ddr.10204
- H. Harada;
- M. Tsukimoto;
- A. Ikari;
- K. Takagi;
- Y. Suketa
- Article
9
- Drug Development Research, 2003, v. 59, n. 1, p. 72
- Marko Kaulich;
- Franziska Streicher;
- Ralf Mayer;
- Ingrid Müller;
- Christa E. Müller
- Article
10
- Drug Development Research, 2003, v. 59, n. 1, p. 64
- Markus Glänzel;
- Ralph Bültmann;
- Klaus Starke;
- August Wilhelm Frahm
- Article
11
- Drug Development Research, 2003, v. 59, n. 1, p. 56, doi. 10.1002/ddr.10201
- Kazuhide Inoue;
- Makoto Tsuda;
- Schuichi Koizumi
- Article
12
- Drug Development Research, 2003, v. 59, n. 1, p. 82
- Anna-Karin Wihlborg;
- Johnny Slätt;
- Xiangyang Sun;
- Xiao-He Zhao;
- Jan Bergman;
- Thomas Hedner;
- David Erlinge
- Article
13
- Drug Development Research, 2003, v. 59, n. 1, p. 30, doi. 10.1002/ddr.10199
- Jean-Marie Boeynaems;
- Françoise Wilkin;
- Frédéric Marteau;
- Xavier Duhant;
- Pierre Savi;
- Nathalie Suarez Gonzalez;
- Bernard Robaye;
- Didier Communi
- Article
14
- Drug Development Research, 2003, v. 59, n. 1, p. 1, doi. 10.1002/ddr.10196
- Richard J. Hughes;
- Brian Torres;
- Alexander Zambon;
- David Arthur;
- Christine Bohmann;
- L. Christian Rump;
- Paul A. Insel
- Article
15
- Drug Development Research, 2003, v. 59, n. 1, p. 23, doi. 10.1002/ddr.10195
- John R. Fozard;
- Bruno Tigani;
- Cedric Wolber;
- Iwan Williams;
- Lazzaro Mazzoni;
- Jason P. Hannon
- Article
16
- Drug Development Research, 2003, v. 59, n. 1, p. 152, doi. 10.1002/ddr.10194
- Edward H. Abraham;
- Anna Y. Salikhova;
- Eugen B. Hug
- Article
17
- Drug Development Research, 2003, v. 59, n. 1, p. 136
- Jesús Pintor;
- Assumpta Peral;
- Teresa Peláez;
- Gonzalo Carracedo;
- Alfredo Bautista;
- Charles H. V. Hoyle
- Article
18
- Drug Development Research, 2003, v. 59, n. 1, p. 128
- Ivana Novak;
- Jan Amstrup;
- Katrine L. Henriksen;
- Susanne E. Hede;
- Christiane E. Sørensen
- Article
19
- Drug Development Research, 2003, v. 59, n. 1, p. 171, doi. 10.1002/ddr.10191
- Francesco Di Virgilio;
- Davide Ferrari;
- Marco Idzko;
- Elisabeth Panther;
- Johannes Norgauer;
- Andrea la Sala;
- Giampiero Girolomoni
- Article
20
- Drug Development Research, 2003, v. 59, n. 1, p. 14, doi. 10.1002/ddr.10177
- Article
21
- Drug Development Research, 2003, v. 59, n. 1, p. 8, doi. 10.1002/ddr.10174
- Hiroyuki Fujimori;
- Hidemitsu Pan-Hou
- Article
22
- Drug Development Research, 2003, v. 59, n. 1, p. 146, doi. 10.1002/ddr.10172
- Pieter C. Dagnelie;
- Hendrik J. Agteresch
- Article
23
- Drug Development Research, 2003, v. 59, n. 1, p. 49
- Kerstin Wirkner;
- Laszlo Köles;
- Susanna Fürst;
- Peter Illes
- Article